Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Measuring GPX4 in Blood of People With Spine Arthritis

Measures GPX4 levels in blood of adults with ankylosing spondylitis or axial psoriatic arthritis.

Plain-language title generated from the registry record
Registry title: Identification of Serum Level of Glutathione Peroxidase 4

Key facts

Where
Asyut, EgyptSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 85 years old?

Source: NCT06554392, who can take part

Where in Egypt

  • Faculty of Medicine Assiut UniversityAsyut, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Assiut University
Trial code
NCT06554392
Record updated
5 November 2026
Original description
* Analysis of the level of glutathione peroxidase 4 (GPX4) in ankylosing spondylitis and axial psoriatic arthritis patients. * The association of glutathione peroxidase 4 (GPX4) with disease activity and severity in ankylosing spondylitis and axial psoriatic arthritis patients.Read full original descriptionShow less

Identification of Glutathione Peroxidase 4 in Detecting Ferroptosis in Ankylosing Spondylitis and Axial Psoriatic Arthritis Patients .

* Analysis of the level of glutathione peroxidase 4 (GPX4) in ankylosing spondylitis and axial psoriatic arthritis patients. * The association of glutathione peroxidase 4 (GPX4) with disease activity and severity in ankylosing spondylitis and axial psoriatic arthritis patients.

Inclusion: Patients diagnosed as ankylosing spondylitis according to ASAS criteria . [13]; Patients diagnosed as psoriatic arthritis according to CASPAR criteria. [14]; Age (>18).

Exclusion: patients received certain drugs (for example, sulfasalazine, artemisinin, statins), and experimental reagents (such as erastin) .[16]; Patient with other autoimmune Rheumatic diseases; patients with any of the following conditions: I) severe liver and kidney dysfunction; II) hematopoietic diseases; III) infectious diseases; IV) tumors; or V) other wasting diseases. [15].

ClinicalTrials.gov NCT06554392